Rockwell Medical Inc (RMTI) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.005x

Based on the latest financial reports, Rockwell Medical Inc (RMTI) has a cash flow conversion efficiency ratio of -0.005x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-167.00K) by net assets ($35.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Rockwell Medical Inc to measure how much of total assets are equity-financed.

Rockwell Medical Inc - Cash Flow Conversion Efficiency Trend (1997–2025)

This chart illustrates how Rockwell Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Rockwell Medical Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Rockwell Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rockwell Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CL Educate Limited
NSE:CLEDUCATE
0.060x
Eurotel SA
WAR:ETL
0.124x
BIONXT SOLUTIONS INC.
F:BXT
0.244x
Bluglass Ltd
AU:BLG
0.000x
Agrometal S.A.I.
BA:AGRO
0.042x
ERREDUE S.P.A.
F:Z9H
N/A
Urbanfund Corp
V:UFC
0.028x
ORTOMA AB B
F:82Y
-0.120x

Annual Cash Flow Conversion Efficiency for Rockwell Medical Inc (1997–2025)

The table below shows the annual cash flow conversion efficiency of Rockwell Medical Inc from 1997 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Rockwell Medical Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $36.98 Million $-659.00K -0.018x -113.82%
2024-12-31 $32.59 Million $4.20 Million 0.129x +129.17%
2023-12-31 $21.29 Million $-9.41 Million -0.442x +63.17%
2022-12-31 $14.11 Million $-16.93 Million -1.200x +90.93%
2021-12-31 $2.54 Million $-33.53 Million -13.228x -1424.96%
2020-12-31 $34.17 Million $-29.64 Million -0.867x +35.33%
2019-12-31 $20.32 Million $-27.25 Million -1.341x -79.17%
2018-12-31 $27.28 Million $-20.42 Million -0.749x -16.70%
2017-12-31 $32.91 Million $-21.11 Million -0.642x -172.81%
2016-12-31 $52.96 Million $-12.45 Million -0.235x +9.77%
2015-12-31 $62.32 Million $-16.24 Million -0.261x -520.51%
2014-12-31 $68.70 Million $4.26 Million 0.062x +100.07%
2013-12-31 $595.54K $-50.66 Million -85.074x -2856.37%
2012-12-31 $-9.96 Million $-30.75 Million 3.086x +622.23%
2011-12-31 $18.24 Million $-10.78 Million -0.591x -959.08%
2010-12-31 $30.54 Million $2.10 Million 0.069x +241.39%
2009-12-31 $29.32 Million $-1.43 Million -0.049x +86.53%
2008-12-31 $11.82 Million $-4.27 Million -0.361x -90.83%
2007-12-31 $17.96 Million $-3.40 Million -0.189x +53.49%
2006-12-31 $8.37 Million $-3.41 Million -0.407x -216.96%
2005-12-31 $3.84 Million $-493.52K -0.128x -142.79%
2004-12-31 $3.42 Million $1.03 Million 0.300x +322.10%
2003-12-31 $3.17 Million $225.42K 0.071x +119.41%
2002-12-31 $3.05 Million $-1.12 Million -0.366x -3.36%
2001-12-31 $2.60 Million $-920.02K -0.354x -104.25%
2000-12-31 $2.86 Million $-496.35K -0.173x +30.61%
1999-12-31 $3.60 Million $-900.00K -0.250x +50.00%
1998-12-31 $4.60 Million $-2.30 Million -0.500x +29.17%
1997-12-31 $1.70 Million $-1.20 Million -0.706x --

About Rockwell Medical Inc

NASDAQ:RMTI USA Drug Manufacturers - Specialty & Generic
Market Cap
$283.79 Million
Market Cap Rank
#23357 Global
#5029 in USA
Share Price
$7.19
Change (1 day)
+1.27%
52-Week Range
$0.55 - $7.19
All Time High
$141.02
About

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more